miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer

Oncotarget

Volumn 6, Issue 31, 2015, Pages 31958-31984

  Li, Haiyan ^a   Li, Jiao ^b   Jia, Song ^b   Wu, Mengying ^a   An, Jiahui ^a   Zheng, Qidi ^a   Zhang, Wei ^a   Lu, Dongdong ^a  

^a TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Early growth response protein 1; Hepatoma; LincRNA H19; microRNA675; Pyruvate kinase M2

Indexed keywords

DIMER; EARLY GROWTH RESPONSE FACTOR 1; HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1ALPHA; HETEROCHROMATIN PROTEIN 1BETA; HETEROCHROMATIN PROTEIN 1GAMMA; HISTONE H3; HISTONE H3 LYSINE 27; HISTONE H3 LYSINE 9; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA H19; MICRORNA; MICRORNA 675; PYRUVATE KINASE; PYRUVATE KINASE M2; UNCLASSIFIED DRUG; EGR1 PROTEIN, HUMAN; H19 LONG NON-CODING RNA; MESSENGER RNA; MIRN675 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; RECEPTOR OCCUPANCY; RNA TRANSCRIPTION; RNA TRANSLATION; SUMOYLATION; UPREGULATION; ACETYLATION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ACETYLATION; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; EARLY GROWTH RESPONSE PROTEIN 1; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84945545596     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5579     Document Type: Article

References (67)

1. Li D, Kang J, Golas BJ, Yeung VW, Madoff DC. Minimally invasive local therapies for liver cancer. Cancer Biol Med. 2014;11:217-36.
2. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G, Reik W. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 2012;14:659-65.
3. Dudek KA, Lafont JE, Martinez-Sanchez A, Murphy CL. Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes.J Biol Chem. 2010;285:24381-7.
4. Kim NH, Choi SH, Lee TR, Lee CH, Lee AY.Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma. J Invest Dermatol. 2014;134:2967-76.
5. Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, Qian J, Liu N, You Y. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675.PLoS One. 2014;9:e86295.
6. Goodell MA. Parental permissions: H19 and keeping the stem cell progeny under control.Cell Stem Cell. 2013;13:137-8.
7. Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J, Yu J.lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014 ;281:3766-75.
8. Gao WL, Liu M, Yang Y, Yang H, Liao Q, Bai Y, Li YX, Li D, Peng C, Wang YL. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1).RNA Biol. 2012;9:1002-10.
9. Schmitz KJ, Helwig J, Bertram S, Sheu SY, Suttorp AC, Seggewiss J, Willscher E, Walz MK, Worm K, Schmid KW. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.J Clin Pathol. 2011;64:529-35.
10. Aygün O, Mehta S, Grewal SI. HDAC-mediated suppression of histone turnover promotes epigenetic stability of heterochromatin.Nat Struct Mol Biol. 2013;20:547-54.
11. Figueiredo ML, Philip P, Stenberg P, Larsson J. HP1a recruitment to promoters is independent of H3K9 methylation in Drosophila melanogaster.PLoS Genet. 2012;8:e1003061.
12. Schuldt A. Chromatin: RNA eviction by HP1. Nat Rev Mol Cell Biol. 2012;13:478-9.
13. Lee YH, Kuo CY, Stark JM, Shih HM, Ann DK. HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response.Nucleic Acids Res. 2013;41:5784-98.
14. Ayrapetov MK, Gursoy-Yuzugullu O, Xu C, Xu Y, Price BD. DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin.Proc Natl Acad Sci U S A. 2014;111:9169-74.
15. Zhang BL, Ni HB, Liu J, Lei Y, Li H, Xiong Y, Yao R, Yu ZQ, Gao DS. EGR1 participates in abnormally high gdnf gene transcription mediated by histone hyperacetylation in glioma cells.Biochim Biophys Acta. 2014;1839:1161-9.
16. Salotti J, Sakchaisri K, Tourtellotte WG, Johnson PF. An Arf-Egr-C/EBPβ Pathway Linked to Ras-Induced Senescence and Cancer.Mol Cell Biol. 2015;35:866-83.
17. Stoddart A, Fernald AA, Wang J, Davis EM, Karrison T, Anastasi J, Le Beau MM. Haploinsufficiency of del (5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.Blood. 2014;123:1069-78.
18. Kang HS, Ock J, Lee HJ, Lee YJ, Kwon BM, Hong SH. Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death.Cancer Lett. 2013;329:217-27.
19. Saayman S, Ackley A, Turner AM, Famiglietti M, Bosque A, Clemson M, Planelles V, Morris KV. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther. 2014;22:1164-75.
20. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM.An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 1995, 9: 2079-89.
21. Bergström R, Whitehead J, Kurukuti S, Ohlsson R.CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain. Cell Cycle 2007, 6: 450-4.
22. Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D. Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity. Cancer Research 2012, 72: 6403-13.
23. Takeuchi S, Hofmann WK, Tsukasaki K.Loss of H19 imprinting in adult T-cell leukaemia/lymphoma. Br. J. Haematol. 2007, 137: 380-1.
24. Arima T, Matsuda T, Takagi N, Wake N.Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet. Cytogenet. 1997, 93: 39-47
25. Banet G, Bibi O, Matouk I.Characterization of human and mouse H19 regulatory sequences. Mol. Biol. Rep. 2000, 27: 157-65.
26. Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A.H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int. J. Gynecol. Cancer 2004, 14:521-5.
27. Gao ZH, Suppola S, Liu J, Heikkilä P, Jänne J, Voutilainen R.Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. J. Clin. Endocrinol. Metab. 2002, 87: 1170-6.
28. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ.Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells.Carcinogenesis 2002; 23: 1885-95.
29. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006, 66: 5330-7.
30. Li H, Yu B, Li J, Su L, Yan M, Zhu Z, Liu B. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5:2318-29.
31. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E.The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2: e845.
32. Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, AlSharef W, De-Groot N, Hochberg A.Possible physiological role of H19 RNA. Mol. Carcinog. 2002, 35: 63-74.
33. Venkatraman A, He XC, Thorvaldsen JL, Sugimura R, Perry JM, Tao F, Zhao M, Christenson MK, Sanchez R, Yu JY, Peng L, Haug JS, Paulson A, et al. Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence.Nature. 2013;500:345-9.
34. Fujimori H, Mukai H, Murakami Y, Hemberger M, Hippo Y, Masutani M. The H19 induction triggers trophoblast lineage commitment in mouse ES cells.Biochem Biophys Res Commun. 2013;436:313-8.
35. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi JS, Zhang H, Min W, Bennett AM, Gregory RI, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101-12.
36. Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ, Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, Szendroedi J, Roden M, Flannery C, et al.The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res. 2014;42:13799-811.
37. Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma D, Yi Z, Chen F.Mdig de-represses H19 large intergenic noncoding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin. Oncotarget. 2013;4:1427-37.
38. Medrzycki M, Zhang Y, Zhang W, Cao K, Pan C, Lailler N, McDonald JF, Bouhassira EE, Fan Y. Histone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells.Cancer Res. 2014;74:6463-73).
39. Wong N, De Melo J, Tang D. PKM2, a Central Point of Regulation in Cancer Metabolism.Int J Cell Biol. 2013;2013:242513.
40. Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, Hu Q, Liu N, You Y. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop. Oncotarget. 2015;6:13006-18.
41. Wang HJ, Hsieh YJ, Cheng WC, Lin CP, Lin YS, Yang SF, Chen CC, Izumiya Y, Yu JS, Kung HJ, Wang WC. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.Proc Natl Acad Sci U S A. 2014;111:279-84.
42. Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MA, Sheedy FJ, Gleeson LE, van den Bosch MW, Quinn SR, Domingo-Fernandez R, Johnson DG, Jiang JK, Israelsen WJ, Keane J, et al. Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages.Cell Metab. 2015;21:65-80.
43. Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, Yamamoto H, Doki Y, Mori M, et al. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelialmesenchymal transition.Proc Natl Acad Sci U S A. 2014;111:15526-31.
44. Li L, Zhang Y, Qiao J, Yang JJ, Liu ZR. Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis.J Biol Chem. 2014;289:25812-21
45. Jung Y, Jang YJ, Kang MH, Park YS, Oh SJ, Lee DC, Xie Z, Yoo HS, Park KC, Yeom YI. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.Mol Cells. 2013;35:335-41.
46. Keller KE, Doctor ZM, Dwyer ZW, Lee YS. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.Mol Cell. 2014;53:700-9.
47. Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW, Burga LN, Xie J, Jurczak MJ, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.Cell. 2013;155:397-409.
48. Desai S, Ding M, Wang B, Lu Z, Zhao Q, Shaw K, Yung WK, Weinstein JN, Tan M, Yao J. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.Oncotarget. 2014;5:8202-10.
49. Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, Wei C, Guo F, Chen Y, Lu Z.PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell. 2014;53:75-87.
50. Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long noncoding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.Biochem Biophys Res Commun. 2014;448:315-22.
51. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.Carcinogenesis. 2010 31:350-8.
52. Hernandez JM, Elahi A, Clark CW, Wang J, Humphries LA, Centeno B, Bloom G, Fuchs BC, Yeatman T, Shibata D. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.Ann Surg Oncol. 2013;20 Suppl 3:S625-35.
53. Eissenberg JC, Elgin SC. HP1a: a structural chromosomal protein regulating transcription.Trends Genet. 2014;30:103-10.
54. Azzaz AM, Vitalini MW, Thomas AS, Price JP, Blacketer MJ, Cryderman DE, Zirbel LN, Woodcock CL, Elcock AH, Wallrath LL, Shogren-Knaak MA. Human heterochromatin protein 1a promotes nucleosome associations that drive chromatin condensation.J Biol Chem. 2014;289:6850-61.
55. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.EMBO J. 2003;22:5323-35.
56. Canzio D, Liao M, Naber N, Pate E, Larson A, Wu S, Marina DB, Garcia JF, Madhani HD, Cooke R, Schuck P, Cheng Y, Narlikar GJ. A conformational switch in HP1 releases auto-inhibition to drive heterochromatin assembly. Nature. 2013;496:377-81.
57. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol. 2014;35:9163-9.
58. Guo G, Kang Q, Chen Q, Chen Z, Wang J, Tan L, Chen JL. High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene. FEBS Lett. 2014;588:1780-6.
59. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long noncoding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.Cancer Lett. 2013;333:213-21.
60. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F, Sun SH. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.Carcinogenesis. 2013;34:577-86.
61. Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D. Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity.Cancer Res. 2012;72:6403-13.
62. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.FEBS J. 2012 279:3159-65.
63. Cortés-Cros M, Hemmerlin C, Ferretti S, Zhang J, Gounarides JS, Yin H, Muller A, Haberkorn A, Chene P, Sellers WR, Hofmann F. M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth.Proc Natl Acad Sci U S A. 2013;110:489-94.
64. Wong CC, Au SL, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO.Switching of pyruvate kinase isoform L to m2 promotes metabolic reprogramming in hepatocarcinogenesis. PLoS One. 2014;9:e115036.
65. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 2012 17;150:685-96.
66. Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.Nat Cell Biol. 2012;14:1295-304.
67. Chen CL, Wu JC, Chen GY, Yuan PH, Tseng YW, Li KC, Hwang SM, Hu YC. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol Ther 2015;23:79-88.